Skip to main content
Kent Hoskins, MD, Oncology, Chicago, IL, University of Illinois Hospital

KentHoskinsMD

Oncology Chicago, IL

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Dir. Familial Breast Cancer Program Sr. Research Scientist University of Illinois at Chicago

Dr. Hoskins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hoskins' full profile

Already have an account?

  • Office

    University of Illinois at Chicago, Division of Hematology-Oncology
    840 South Wood Street (MC 713)
    Chicago, IL 60612
    Phone+1 312-996-1581
    Fax+1 312-413-4131
  • Is this information wrong?

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2011
  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1994
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1991
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1988

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1995 - 2026
  • PA State Medical License
    PA State Medical License 1994 - 1996
  • MI State Medical License
    MI State Medical License 1991 - 1995
  • IA State Medical License
    IA State Medical License 1988 - 1991
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Race/Ethnicity and the 21-Gene Recurrence Score with Breast Cancer–Specific Mortality Among US Women  
    Kent F Hoskins, Oana C Danciu, JAMA Oncology

Press Mentions

  • Genomic Assay Changes Minds on HER2+ BC Treatment
    Genomic Assay Changes Minds on HER2+ BC TreatmentMay 17th, 2023
  • Health Equity Initiatives Receive Funding from the American Cancer Society
    Health Equity Initiatives Receive Funding from the American Cancer SocietyMarch 3rd, 2022
  • Individualizing Risk Estimates Increase Mammography Use
    Individualizing Risk Estimates Increase Mammography UseSeptember 10th, 2021
  • Join now to see all

Hospital Affiliations